eleva
Latest round
- Series B
Last raised
- Nov 2006
Total raised
- $7.1M
Investors
- 4
About eleva
Founded in 1999 and headquartered in Freiburg im Breisgau, Germany, Eleva Biologics specializes in biologic therapies.Eleva Biologics specializes in developing innovative biologic therapies that address complex medical needs, particularly in the realm of orphan diseases. The company’s flagship product, Factor H (CPV-104), targets complement disorders and represents a significant advancement in the treatment landscape for patients with these rare conditions. Eleva's transformative manufacturing platform utilizes moss technology to produce biologics that are traditionally challenging to manufacture, enhancing the accessibility and efficacy of these critical therapies. Their product offerings cater primarily to healthcare institutions, specialty pharmacies, and research organizations, with a focus on markets in Europe and North America.10 for 2021.Eleva GmbH plans to expand its product line with new biologic therapies targeting additional orphan diseases within the next two years. The company is also looking to enter new geographic markets, specifically targeting North America and select regions in Asia by 2024.
Who invested in eleva
4 investors across 1 round
See all investors in eleva
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 25, 2006
Amount
$7.1M
Investors
Questions about eleva
Who invested in eleva?
eleva has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has eleva raised?
eleva has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did eleva last raise money?
eleva's most recent round on record is a Series B, in Nov 2006.
What does eleva do?
Founded in 1999 and headquartered in Freiburg im Breisgau, Germany, Eleva Biologics specializes in biologic therapies.
Where is eleva headquartered?
eleva is headquartered in Freiburg im Breisgau, Germany.
Which VCs invest in companies like eleva?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at eleva's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like eleva? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.